..government regulatory agencies are highly political and biased towards who "butters" their bread.
What, are you suggesting that there is an element of bias in the US drug approval system?
Surely not...
I'd rather they partnered with Huawei to ensure that their therapy has a fighting chance of reaching patients (and changing the face of cancer treatment), than by selling out to the status quo, and have this treatment filed under 'no further action'.
The FDA doesn't regulate the whole world fortunately.